Vote Scores

Home / Companies / XBiotech Inc. / 29 Aug 2025

Meeting · year to 30 June 202651 filers reporting

XBiotech Inc.: meeting of 29 Aug 2025

Votes reported on Form N-PX, item by item

51 Form N-PX filers reported votes at the XBiotech Inc. meeting of 29 Aug 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

5 nominees; 92.6% of reported votes for; 4 filers withheld from or voted against at least one nominee.

105 vote records from 12 filers. 0 of the 11 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

91.7% for0.0% against8.3% other0.0% against management12 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

74 vote records from 51 filers. 36 of the 45 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

15.7% for70.6% against13.7% other80.0% against management51 filers8.8% for86.6% against4.6% other91.1% against management1,815,618 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

21 vote records from 12 filers. 1 of the 11 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

83.3% for8.3% against8.3% other9.1% against management12 filers91.3% for8.7% against8.7% against management678,279 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

21 vote records from 12 filers. 9 of the 11 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

16.7% for75.0% against8.3% other81.8% against management12 filers76.4% for23.6% against23.6% against management678,279 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForAgainst *For
BlackRock and iSharesForAgainst *For
FidelityForAgainst *For
DimensionalForAgainst *For
State Street and SPDRNo reportForNo report
American CenturyForAgainst *For
EquitableForAgainst *For
Charles SchwabNo reportAgainst *No report
Goldman SachsForForFor
PGIM and PrudentialForAgainst *For
Jackson National fundsForAgainst *For
Northern Trust and FlexSharesSplit or no voteForSplit or no vote
First TrustNo reportAgainst *No report
Guggenheim and RydexForAgainst *For
BNY MellonNo reportAgainst *No report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the XBiotech Inc. meeting?

51 Form N-PX filers reported votes at the meeting of 29 Aug 2025. On say-on-pay, 36 of 45 voted against management (80.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by XBiotech Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for XBiotech Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing XBiotech Inc. with a meeting date within three days of 29 Aug 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.